Product Description
Overall, the global inlay and onlay market was valued at $1.78 billion in 2023. This is expected to remain steady over the forecast period at a CAGR of 0.6% to reach around $1.86 billion.
The full report suite on the global market includes inlays and onlays made of the gold, zirconia, ceramic and composite resin materials.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID-19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Inlay and Onlay Market Share Insights 
- In 2023, Glidewell Dental led the inlay and onlay market, bolstered by its strong U.S. presence and expansions in Europe and Latin America. As market consolidation continues, major competitors like Glidewell Dental are increasing their shares through acquisitions and growth. The company’s large size grants it significant bargaining power and a strong brand image in the dental market.
- Colosseum Dental Group ranked second, expanding its European presence by merging with Curaeos in October 2021. Colosseum operates over 620 clinics and 50 labs across Europe, while Curaeos runs 186 clinics and 54 labs.
- National Dentex Corporation was the third-leading competitor, boasting the largest network of individual labs in North America. It continues to grow by acquiring smaller dental labs. In April 2021, it acquired Dental Services Group (DSG), a large network of full-service labs in North America, and over 100 affiliate labs in the U.S., Canada, and Europe. Additional acquisitions in 2021 and 2022 included Dental Arts, Fager Dental Lab, Swan Dental Lab, and Biotech Dental Prosthetics.
Market Segmentation Summary
- Inlay and Onlay Market
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2022 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
